Sanofi Profit Beats Estimates With New CEO Hudson at Helm

(Bloomberg) -- Sanofi’s key growth driver, a drug for eczema and asthma, helped the French pharma giant report earnings that beat analysts’ estimates in Paul Hudson’s first quarter as chief executi...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.